Clinical and Functional Outcomes Associated with Quality of Life in Patients with Lymphangioleiomyomatosis: A Cross-Sectional Study

Lynn E, Forde SH, Franciosi AN et al (2024) LAM prevalence consortium updated prevalence of lymphangioleiomyomatosis in Europe. Am J Respir Crit Care Med 209(4):456–459. https://doi.org/10.1164/rccm.202310-1736LE

Article  PubMed  Google Scholar 

Taveira-DaSilva AM, Moss J (2015) Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol 7(7):249–257. https://doi.org/10.2147/CLEP.S50780

Article  PubMed  PubMed Central  Google Scholar 

McCormack FX, Gupta N, Finlay GR et al (2016) Official American thoracic society/Japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med 194(6):748–761. https://doi.org/10.1164/rccm.201607-1384ST

Article  PubMed  PubMed Central  Google Scholar 

Cotin V (2014) Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases. ERJ 43:966–969. https://doi.org/10.1183/09031936.00025314

Article  CAS  Google Scholar 

Araujo MS, Baldi BG, Freitas CS et al (2016) Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial. Eur Respir J 47(5):1452–1460. https://doi.org/10.1183/13993003.01683-2015

Article  CAS  PubMed  Google Scholar 

Baldi BG, Freitas CS, Araujo MS et al (2014) Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre. Sarcoidosis Vasc Diffuse Lung Dis 31(2):129–135

PubMed  Google Scholar 

Baldi BG, Albuquerque AL, Pimenta SP et al (2012) Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis. Am J Respir Crit Care Med 186(4):341–348. https://doi.org/10.1164/rccm.201203-0372OC

Article  PubMed  Google Scholar 

Sousa TC, Jardim JR, Jones P (2000) Validação do Questionário do Hospital Saint George na Doença Respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Pneumol 26(3):119–128

Article  Google Scholar 

Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

Article  PubMed  Google Scholar 

Zimmermann CS, Carvalho CR, Silveira KR et al (2007) Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res 40:179–187. https://doi.org/10.1590/s0100-879x2007000200004

Article  CAS  PubMed  Google Scholar 

Singh SJ, Sodergren SC, Hyland ME et al (2001) A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. Respir Med 95(1):71–77

Article  CAS  PubMed  Google Scholar 

Buss AS, Silva LMC (2009) Comparative study of two quality of life questionnaires in patients with COPD. J Bras Pneumol 35(4):318–324. https://doi.org/10.1590/s1806-37132009000400005

Article  PubMed  Google Scholar 

Oliveira MR, Wanderley M, Freitas CSG et al (2024) Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study. ERJ Open Res 10(2):00759–02023. https://doi.org/10.1183/23120541.00759-2023

Article  PubMed  PubMed Central  Google Scholar 

Kato M, Kanehiro Y, Yoshimi K et al (2018) Multicenter lymphangioleiomyomatosis sirolimus trial for safety study group. COPD assessment test as a possible tool for evaluating health-related quality of life in lymphangioleiomyomatosis. Respir Investig 56(6):480–488. https://doi.org/10.1016/j.resinv.2018.07.004

Article  PubMed  Google Scholar 

Silva Queiroz D, Marques da Silva CCB, Franco Amaral A et al (2022) Evaluation of maximal exercise capacity through the incremental shuttle walking test in lymphangioleiomyomatosis. Pulmonology. https://doi.org/10.1016/j.pulmoe.2022.04.009

Article  PubMed  Google Scholar 

Rudilla D, Molina M, Valenzuela C et al (2024) A study on the psychological profile and coping with the disease in patients with lymphangioleiomyomatosis. Open Respir Arch 6(3):100327. https://doi.org/10.1016/j.opresp.2024.100327

Article  PubMed  PubMed Central  Google Scholar 

Johnson SR, Cordier JF, Lazor R et al (2010) Review panel of the ERS LAM task force. European respiratory society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J 35(1):14–26. https://doi.org/10.1183/09031936.00076209

Article  CAS  PubMed  Google Scholar 

Schober P, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126(5):1763e1768. https://doi.org/10.1213/ANE.0000000000002864

Article  Google Scholar 

Ryu JH, Moss J, Beck GJ et al (2006) NHLBI LAM registry group. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 173(1):105–111. https://doi.org/10.1164/rccm.200409-1298OC

Article  PubMed  Google Scholar 

Aronson KI, Martin-Schwarze AM, Swigris JJ et al (2023) Pulmonary fibrosis foundation. Validity and reliability of the fatigue severity scale in a real-world interstitial lung disease cohort. Am J Respir Crit Care Med 208(2):188–195. https://doi.org/10.1164/rccm.202208-1504OC

Article  PubMed  PubMed Central  Google Scholar 

Guyatt G, Berman L, Townsend M et al (1987) A measure of quality of life for clinical trials in chronic lung disease. Thorax 42:773–778

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez TY, Pereira CA, dos Santos ML et al (2000) Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 117:1627–1632

Article  CAS  PubMed  Google Scholar 

Stickland MK, Neder JA, Guenette JA et al (2022) Using cardiopulmonary exercise testing to understand dyspnoea and exercise intolerance in respiratory disease. Chest 161(6):1505–1516. https://doi.org/10.1016/j.chest.2022.01.021

Article  PubMed  Google Scholar 

Stöber A, Lutter JI, Schwarzkopf L et al (2021) Impact of lung function and exacerbations on health-related quality of life in COPD patients within one year: real-world analysis based on claims data. Int J Chron Obstruct Pulmon Dis 21(16):2637–2651. https://doi.org/10.2147/COPD.S313711

Article  Google Scholar 

Moua T, Kubbara A, Novotny P et al (2021) Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect. ERJ Open Res. https://doi.org/10.1183/23120541.00011-2021

Article  PubMed  PubMed Central  Google Scholar 

Swigris JJ, Kuschner WG, Jacobs SS et al (2005) Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 60(7):588–594. https://doi.org/10.1136/thx.2004.035220

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ryerson CJ, Berkeley J, Carrieri-Kohlman VL et al (2011) Depression and functional status are strongly associated with dyspnoea in interstitial lung disease. Chest 139:609–616

Article  PubMed  Google Scholar 

Holland AE, Fiore JF Jr, Bell EC et al (2014) Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology 19:1215–1221

Article  PubMed  Google Scholar 

Ryerson CJ, Arean PA, Berkeley J et al (2012) Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 17:525–532

Article  PubMed  Google Scholar 

Comments (0)

No login
gif